Matthew M Seavey Ph.D, MBA

Matthew M Seavey Ph.D, MBA

Company: Heat Biologics, Inc.

Job title: VP of Research


Agonizing Over Treg Expansion to Treat Human Disease: An Update on Our TNFRSF25-Agonist, PTX-35 4:00 pm

Describing a clinical-stage Treg immunomodulator with utility in both oncology and auto/inflammation Demonstrating preclinical efficacy in several indications including transplantation, autoimmunity, and metabolic diseases Expanding plans for new indications & modalities – opportunities for partnershipsRead more

day: Day one Track 2 PM

Expert Panel: Optimizing Routes of Administration & Delivery Mechanisms to Induce Timely Treg Specific Activation With 11:30 am

Read more

day: Day two track 2 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.